Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
11/2005
11/03/2005WO2005102308A2 Crystalline and amorphous forms of efaproxiral sodium
11/03/2005WO2005080316A3 Modulators of cannabinoid receptors
11/03/2005WO2005079541A3 Terephthalamide peptidomimetic compounds and methods
11/03/2005US20050245640 Hot melt inks containing a carrier derived from alkylketene dimers
11/03/2005US20050245607 N-bisaryl- and n-aryl-cylcloakylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/03/2005US20050245500 Beta-ketoamide compounds with MCH antagonistic activity
11/03/2005US20050245491 Tetracycline derivatives and methods of use thereof
11/03/2005US20050245408 Sustained release; controlled chemical cascade; storage stability
11/03/2005CA2563756A1 Phenyl acetamides
11/03/2005CA2563751A1 Crystalline and amorphous forms of efaproxiral sodium
11/03/2005CA2563180A1 Non-nucleoside reverse transcriptase inhibitors
11/02/2005EP1591496A1 Hot melt ink having carrier derived from alkylketene dimer
11/02/2005EP1591441A1 Carboxylic acid compounds
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590319A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
11/02/2005EP1590318A2 Modulators (inhibitors/activators) of histone acetyltransferases
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/02/2005EP1242363B1 Cd45 inhibitors
11/02/2005EP1005493B1 Antiviral protease inhibitors
11/02/2005CN1690137A Heat melted printing ink of carrier derive from alkyl ketene dimer
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960588 Tryptase inhibitors
11/01/2005US6960581 1-amino-2-hydroxy-butane or 2-hydroxy-butanamide derivatives
11/01/2005US6960355 Modified amino acid compounds useful in delivery of active agents
10/2005
10/28/2005CA2505200A1 Hot melt inks containing a carrier derived from alkylketene dimers
10/27/2005WO2005100505A1 New organic luminescent element
10/27/2005WO2005100323A1 Process for preparing pyridazinone compounds
10/27/2005WO2004016213A3 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
10/27/2005US20050239898 Compounds for use in the treatment of aids and other viral diseases and HIV-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
10/27/2005US20050239896 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke, depression, glaucoma
10/27/2005US20050239849 Substituted phenoxyacetic acids
10/27/2005US20050239828 Spirocyclic amides as cannabinoid receptor modulators
10/27/2005CA2563225A1 Process for preparing pyridazinone compounds
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005CN1687016A New method for synthesizing niclosamide
10/26/2005CN1687015A Synthesis method for water-soluble bisamide oxide
10/26/2005CN1687014A Aqueous phase synthesis method for water-soluble dimethyl half amide oxide
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005US6958417 Process for preparing zolpidem
10/25/2005CA2245490C 3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097773A1 1,1’-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
10/20/2005WO2005058845A3 Novel glucagon antagonists/inverse agonists
10/20/2005WO2005044191A3 Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells
10/20/2005US20050234236 Process for preparing pyridazinone compounds
10/20/2005US20050234131 Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
10/20/2005US20050234121 coating formulations and polymers that utilize a dioxanone containing composition or fatty acid derivative
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005CA2560648A1 1,1'-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
10/19/2005EP1585752A1 Polyene polyketides, processes for their production and their use as a pharmaceutical
10/19/2005EP1200391B1 Calixarene acetamido derivatives, preparation and use thereof for extracting strontium
10/19/2005EP1036057B1 Radio-opaque polymer biomaterials
10/19/2005CN1683303A Novel use of 3, 4-dihydroxy-benzene formaldehyde and its derivatives in treating hypatitis B and virus infectious diseases
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/13/2005WO2005095378A2 Vegetable based dioxanone derivatives, synthesis and uses thereof
10/13/2005WO2005095329A1 Substituted benzamide compounds as vr1 receptor antagonists
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005095326A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/13/2005WO2005070910A3 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
10/13/2005US20050228050 Novel stable crystals of substituted phenylpropionic acid derivative and process for producing the same
10/13/2005US20050228033 Voltage-gated sodium channel (VGSC) and prostate voltage sodium channel (PVSC) inhibitors for treating diseases characterized by overabundant or hyperactive VGSC/PVSC's; phenytoin derivatives; use as sodium channel blockers, anti-cancer agents; can be used to limit or prevent PSA growth and metastasis
10/13/2005US20050228020 Beta secretase inhibitors
10/13/2005US20050228017 Novel anticancer compounds
10/13/2005CA2560776A1 Vegetable based dioxanone derivatives, synthesis and uses thereof
10/13/2005CA2560773A1 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/12/2005EP1201235B1 Neuropathy improvers containing nitrogenous compounds as the active ingredient
10/12/2005CN1681780A Biological low-molecular weight derivatives
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681498A Diaryl ethers as opioid receptor antagonist
10/12/2005CN1680332A Method for producing amine derivative
10/12/2005CN1680308A New 3-aryl-2-hydroxypropionic acid derivative I
10/12/2005CN1680287A Ketol fatty acid derivatives and plant growth regulators
10/12/2005CN1680286A Preparation of bar-like zunthoxylum bungeanum acylamide and its use in oral sanitary products
10/12/2005CN1680284A New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
10/12/2005CN1680280A Method for producing amine derivative
10/12/2005CN1222507C Process for production of calcium pantothenate
10/12/2005CN1222501C Novel compounds
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/06/2005WO2005092897A2 2,4,6-phenylsubstituted cyclic ketoenoles
10/06/2005WO2005092836A1 Opioid receptor antagonists
10/06/2005WO2005092326A1 Small molecule antagonists of xiap family proteins
10/06/2005WO2005092317A1 Thyroid receptor agonists
10/06/2005WO2005092305A2 Compounds for treating aids and other diseases
10/06/2005WO2005073216A3 Hcv ns-3 serine protease inhibitors
10/06/2005US20050222524 Apparatus and method for applying variable localized pressure to the human body
10/06/2005US20050222423 Carboxylic acid derivative
10/06/2005US20050222397 such as 4-methyl-6-chloro-7-aminoquinolone; simple to perform, high chemical and isomeric purity product in a high yield; intermediates to azo pigments
10/06/2005US20050222261 2-[2-(4-{2-[ethyl(2-fluorobenzyl)amino]-2-oxoethoxy}phenyl)ethoxy]benzoic acid; peroxisome proliferator-activated receptors alfa agonist; antidiabetic, hypotensive agent; obesity, elevated VLDL (Very Low Density Lipoproteins) and reduced HDL (High Density Lipoprotein) concentrations
10/06/2005US20050222243 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/06/2005DE102004014620A1 2,4,6-phenylsubstituierte cyclische Ketoenole 2,4,6-substituted cyclic ketoenols
10/06/2005CA2562633A1 Thyroid receptor agonists
10/06/2005CA2561076A1 2,4,6-phenylsubstituted cyclic ketoenoles
10/06/2005CA2560922A1 Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
10/06/2005CA2557794A1 Opioid receptor antagonists
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581480A1 Cyclopentil-substituted glutaramide compounds as endopeptidasev inhibitors
10/05/2005EP1581476A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 157